Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial

Faster, Cleaner, Better.

Pernix Therapeutics Holdings Inc (PTXTQ)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Cash Flow for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	12-2012	12-2011	12-2010	12-2009	12-2008
Cash Flows From Operating Activities
Net Income	-1,410	8,348	9,309	9,199	-538
Depreciation Amortization	3,202	2,303	1,239	211	3
Income taxes - deferred	-1,836	-2,273	-3,055	N/A	N/A
Accounts receivable	-3,886	-5,843	-8,361	-1,651	37
Accounts payable and accrued liabilities	-1,843	740	1,576	390	-416
Other Working Capital	-5,487	-1,770	-2,408	-148	-385
Other Operating Activity	9,334	7,894	6,368	1,942	-254
Operating Cash Flow	$-1,926	$9,397	$4,667	$9,943	$-1,554

Cash Flows From Investing Activities
PPE Investments	-318	-176	-120	-112	-16
Net Acquisitions	-63,729	N/A	-3,823	-450	N/A
Purchase Of Investment	N/A	-2,000	-1,503	N/A	N/A
Purchase Sale Intangibles	-850	N/A	N/A	N/A	N/A
Other Investing Activity	-850	0	-250	-170	2,233
Investing Cash Flow	$-64,897	$-2,176	$-5,695	$-733	$2,217

Cash Flows From Financing Activities
Change In Short Term Borrowing	N/A	1,000	5,000	N/A	N/A
Debt Issued	40,054	N/A	N/A	N/A	N/A
Debt Repayment	-121	N/A	N/A	N/A	N/A
Common Stock Issued	24,587	19,549	78	N/A	N/A
Common Stock Repurchased	N/A	N/A	-850	N/A	N/A
Other Financing Activity	-9,225	-1,480	483	-9,506	0
Financing Cash Flow	$55,295	$19,069	$4,710	$-9,506	$N/A

Beginning Cash Position	34,551	8,260	4,579	4,874	7,399
End Cash Position	23,023	34,551	8,260	4,579	8,002
Net Cash Flow	$-11,528	$26,291	$3,682	$-296	$603

Free Cash Flow
Operating Cash Flow	-1,926	9,397	4,667	9,943	-1,554
Capital Expenditure	-326	-176	-120	-112	-16
Free Cash Flow	-2,252	9,222	4,547	9,831	-1,570